Literature DB >> 26813416

Alcoholic Liver Disease and Hepatitis C Chronic Infection.

Alessandro Federico1, Marcello Dallio, Vittorio M Ormando, Ludovico Abenavoli, Mario Masarone, Marcello Persico, Carmela Loguercio.   

Abstract

Alcoholic and virus C hepatitis currently represent the main causes of chronic liver disease worldwide. Every year many people die and are subjected to complex hospitalization and medical assistance due to these pathologies. Alcoholic liver disease and hepatitis C virus chronic infection are often present in the same patient. These two pathologies sinergically act in determining the onset and progression of liver damage that, from the chronic hepatitis staging, may rapidly progress to fibrosis, cirrhosis and hepatocellular carcinoma. In this review we analysed physiopathological aspects and biomolecular interactions that relate ethanol and hepatitis C virus in determining liver damage; moreover we took into account the effect on the natural history of liver disease deriving from the co-presence of these pathologies. Therefore we paid particular attention to the ability of ethanol and hepatitis C virus to in inducing oxidative stress or lipid accumulation, and analyzed the basic mechanisms of fibrogenesis that both diseases have got, amplified by their co-presence in the same patient. Finally we paid attention to the oncogenetic mechanisms inducing hepatocellular carcinoma and variability of response to antiviral therapy that derives from alcohol abuse in a subject affected by C hepatitis.

Entities:  

Mesh:

Year:  2016        PMID: 26813416     DOI: 10.2174/1574887111666160126144940

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  3 in total

1.  Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors.

Authors:  Janne Fuglsang Hansen; Sofie Hallager; Anne Øvrehus; Nina Weis; Peer Brehm Christensen; Court Pedersen
Journal:  Open Forum Infect Dis       Date:  2017-11-22       Impact factor: 3.835

Review 2.  Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.

Authors:  Alessandro Federico; Marcello Dallio; Carmelina Loguercio
Journal:  Molecules       Date:  2017-01-24       Impact factor: 4.411

3.  Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.

Authors:  Dong Hyun Sinn; Danbee Kang; Yun Soo Hong; Kwang Cheol Koh; Eliseo Guallar; Juhee Cho; Geum-Youn Gwak
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.